-
✅
Jan. 14
-
📣
Jan. 14
-
To be announced
Prof. Dr. Klaus GramannJan. 14
-
Toward Clinical Trial Readiness: Cross-Species EEG Biomarkers in Neurodevelopmental Disorders
Dr. John J. FoxeJan. 14
-
☕
Jan. 14
-
The utility of cognitive ERPs in the management of addictive disorders.
Dr. Salvatore CampanellaJan. 14
-
Hormones as a hidden source of variability: EEG and psychophysiological insights into women's brain health
Prof. Dr. Ramunė GrikšienėJan. 14
-
Peak Alpha Frequency as a Biomarker of Neuroimmune Vulnerability to Chronic Postsurgical Pain
Dr. Ali MazaheriJan. 14
-
🥗
Jan. 14
-
EEG Biomarkers, AI and Precision Psychiatry
Prof. Dr. Sebastian OlbrichJan. 14
Biography:
Albino J. Oliveira Maia trained in medicine at the Faculty of Medicine of the University of Porto, and then did doctoral and post-doctoral work in Neuroscience at Duke University and the Champalimaud Foundation, and completed a master’s degree in public health at Harvard University. After academic training, Albino specialized in Psychiatry and worked as a Psychiatrist in Lisbon. He is currently Director of the Neuropsychiatry Unit at the Champalimaud Clinical Centre, Director of the Digital Neurotherapeutics Centre at the Centre for Restorative Neurotechnology, PI at the Neuroscience of Disease Programme, and professor of Psychiatry and Neuroscience at NOVA Medical School in Lisbon. Albino is also coordinator of the Psychiatry Working Group at the Office for the National Exam for Access to Specialty Training (Portugal), President-elect of the Portuguese Society of Psychiatry and Mental Health, President of the Scientific Council for the Portuguese OCD Foundation and President of the Ethics Committee at the Institute for Addictive Behaviors and Addictions.